SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Optimer Pharmaceuticals, Inc.r's DIFICID® (fidaxomicin) Tablets Approved by Health Canada for the Treatment of Clostridium Difficile Infection and Now Available to Canadian Patients